How Medicare’s Aduhelm decision revived old questions about new drugs
(By Kerry Dooley Young for STAT) Medicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s
Read more(By Kerry Dooley Young for STAT) Medicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s
Read more(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published May 18, 2023) The FDA’s accelerated approval of Aduhelm
Read more(By Andrew Joseph for STAT) For the second time in one extended family, researchers have identified a person who seemed
Read more(By Sarah Boden for NPR) Angela Reynolds knew her mother’s memory was slipping, but didn’t realize how bad things had
Read more(Source -The Associated Press published May 4, 2023 by NPR) WASHINGTON — Eli Lilly and Co. said Wednesday its experimental
Read more(By Rylee Wilson for Becker’s Hospital Review) Twenty-six state attorneys general are asking Medicare to cover monoclonal antibody treatments for
Read more(By Jakob Emerson for Becker’s Hospital Review) Eli Lilly is expecting CMS to reverse course on its Medicare coverage policies
Read moreBy Dr. Peter Kaboli, Acting executive director, Office of Rural Health for VA News on March 15, 2023 Every night
Read more(By Judith Graham for Kaiser Health News) There’s no cure, yet, for Alzheimer’s disease. But dozens of programs developed in
Read more(Source – www.cms.gov) Alzheimer’s disease is a devastating illness that affects millions of Americans and their families. The Centers for
Read more